Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Its role in research is exploratory and focused on mechanistic understanding, rather than producing therapeutic outcomes
No direct trial evidence No published clinical trial has evaluated the four-peptide KLOW combination together, and the doses cited above are extrapolated from individual-component research and community protocols, not validated as a synergistic dose for the blend
GHK-Cu has some research suggesting anti-cancer properties, but the same caution applies
Journal of Physiology-Paris 87:313327 Sikiric P, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH (2018) Novel cytoprotective mediator, stable gastric pentadecapeptide BPC 157
Keep consecutive injections at least one inch apart from any previous site, and avoid any area that is bruised, scarred, inflamed, or still tender from a previous dose
For a broader overview of the peptide research landscape, see the complete guide to peptides or the peptide glossary
